Zhang, Fan
Kumano, Masafumi
Beraldi, Eliana
Fazli, Ladan
Du, Caigan
Moore, Susan
Sorensen, Poul
Zoubeidi, Amina
Gleave, Martin E.
Article History
Received: 3 March 2014
Accepted: 6 November 2014
First Online: 12 December 2014
Competing interests
: By way of disclosure of conflict of interest, the University of British Columbia has submitted patent applications on OGX-011, listing Dr. Gleave as the inventor. This IP has been licensed to OncoGenex Technologies, a Vancouver-based biotechnology company that Dr. Gleave has founding shares in.